Researcher
Marc Van Ranst
- Disciplines:Microbiology, Systems biology, Laboratory medicine
Affiliations
- Laboratory of Clinical Microbiology (Division)
Member
From1 Oct 2005 → 31 Dec 2006 - Laboratory of Clinical and Epidemiological Virology (Rega Institute) (Division)
Member
From1 Oct 1999 → Today
Projects
1 - 10 of 29
- Environmental sampling as a tool to monitor enteric virus epidemiologyFrom1 Feb 2023 → TodayFunding: FWO fellowships
- SDS/EDTA-treated chromatography paper strips for laboratory confirmation of monkeypox virus in the context of the global mpox epidemiologyFrom2 Aug 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- The assessment of virome composition and dynamic in blood transfusion settingFrom1 Oct 2020 → TodayFunding: BOF - projects
- Development of a new point-of-care COVID-19 screening using exhaled-breath volatilome analysis.From1 Apr 2020 → 31 Mar 2021Funding: IOF - technology validation in lab
- Microbial Communities in Biomedical and Environmental Areas, and Systems BiologyFrom1 Jan 2018 → 31 Aug 2021Funding: H2020-EU.4. - Spreading excellence and widening participation
- Third generation sequencing and herpesvirus diversity: Towards complete double-stranded DNA virus genomesFrom8 Dec 2017 → 20 Dec 2021Funding: Own budget, for example: patrimony, inscription fees, gifts
- Metagenomic analysis of the virome of the honeybee (Apis mellifera) in the Czech RepublicFrom1 Oct 2017 → 30 Sep 2019Funding: BOF - Bilateral scientific cooperation
- Rotavirus in Bats and Humans: Genetic Diversity and Gastroenteritis in the Post-Vaccine EraFrom1 Oct 2017 → 25 Jan 2022Funding: Own budget, for example: patrimony, inscription fees, gifts
- Host switching pathogens, infectious outbreaks and zoonosis; a Marie Sklodowska-Curie Training NetworkFrom1 Apr 2017 → 31 Mar 2021Funding: H2020 - Skills and Career Development (Marie Skłodowska-Curie) actions
- Development and application of filovirus reverse genetics systems for antiviral compound screeningFrom1 Jan 2017 → 24 Sep 2021Funding: FWO Strategic Basic Research Grant
Publications
21 - 30 of 362
- Rotavirus vaccine-derived cases in Belgium: Evidence for reversion of attenuating mutations and alternative causes of gastroenteritis(2022)
Authors: Daan Jansen, Marc Van Ranst, Jelle Matthijnssens
Pages: 5114 - 5125 - Fast detection of SARS-CoV-2 variants including Omicron using one-step RT-PCR and Sanger sequencing(2022)
Authors: Annabel Rector, Marc Van Ranst, Piet Maes, Bert Vanmechelen
- Two Separate Clusters of SARS-CoV-2 Delta Variant Infections in a Group of 41 Students Travelling from India: An Illustration of the Need for Rigorous Testing and Quarantine(2022)
Authors: Lize Cuypers, Sarah Gorissen, Marc Van Ranst, Johan Van Weyenbergh, Piet Maes, Guy Baele, Pieter Vermeersch, Emmanuel Andre
- A confirmed case of COVID-19 reinfection with a genetically distinct strain: a case report from Belgium(2022)
Authors: Marc Van Ranst, Katrien Lagrou, Piet Maes
Pages: 686 - 687 - Lower persistence of anti-nucleocapsid compared to anti-spike antibodies up to one year after SARS-CoV-2 infection(2022)
Authors: Natalie Lorent, Gijs Van Pottelbergh, Lode Godderis, Marc Van Ranst, Emmanuel Andre, Katrien Lagrou, Pieter Vermeersch
- Cytidine nucleoside analog is an effective antiviral drug against Trichomonasvirus(2022)
Authors: Marc Van Ranst, Johan Neyts
Pages: 191 - 198 - The virota and its transkingdom interactions in the healthy infant gut(2022)
Authors: Gwen Falony, Bert Vanmechelen, Lore Van Espen, Daan Jansen, Piet Maes, Karoline Faust, Marc Van Ranst, Jeroen Raes, Jelle Matthijnssens
- VALCOR: a protocol for the validation of SARS-corona virus-2 assays(2022)
Authors: Lize Cuypers, Marc Van Ranst
- The influence of COVID-19 on routine hematological parameters of hospitalized patients(2022)
Authors: Marc Van Ranst, Nancy Boeckx
Pages: 241 - 246 - Reliable and Scalable SARS-CoV-2 qPCR Testing at a High Sample Throughput: Lessons Learned from the Belgian Initiative(2022)
Authors: Marc Van Ranst, Els Dequeker, Lies Laenen, Emmanuel Andre